Once-daily vanzacaftor-tezacaftor-deutivacaftor was safe and well-tolerated in children with cystic fibrosis, while ...

Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.

A new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...

The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...

Boehringer Ingelheim, the UK Respiratory Gene Therapy Consortium (GTC), IP Group and Oxford BioMedica (OXB) have commenced ...

The Charleston Mom Prom is a charity event hosted by the Cystic Fibrosis Foundation, bringing women together to help make a ...

A Charleston-area roofing company is officially being ejected from its workspace amid complaints that it took hundreds of ...

The genetic disorder cystic fibrosis is unique because it can cause both breathing and digestive problems. Some 40,000 people in the U.S. currently have it, "though this is likely an ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis is being tested in human ...

NARBERTH, Pennsylvania (WPVI) -- "Take A Breather Foundation" based in Narberth is a stress relief outlet for people with cystic fibrosis. Their focus is to provide a "breather" to their recipients, ...